Drugs / Pangramin Plus D. pteronyssinus
Pangramin Plus D. pteronyssinus
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT02123316 Comparator | Jan 2010 → Apr 2014 | allergic rhinitis | Miguel Blanca Gomez | Completed | No outcome recorded |
| Phase 4 | NCT00492076 Comparator | Oct 2006 → May 2008 | allergic asthma | ALK-Abelló A/S | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pangramin Plus D. pteronyssinus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02123316 ↗ |
| Modality | Other / unclassified | “allergen immunotherapy (AIT)” PMID 27008542 ↗ Apr 2016 |
| Route | Subcutaneous | “short course of subcutaneous immunotherapy” NCT00492076 ↗ |